Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with verticals in industries, including artificial intelligence, machine learning, and healthcare. Its products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and dark Web, making predictive analytics. This platform provides insights into market trends and direct customer feedback. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amount of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform.


TSXV:DM - Post by User

Comment by Venatoron Nov 22, 2022 12:21pm
108 Views
Post# 35119045

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Q3

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Q3

Exactly. If another behemoth wants to compete against Telus in the Telehealth field they will want to leap frog the R&D stage. They do this through acquisitions. Telus spent in the 100's of millions in acquisitions for the AI and platforms that became integrated into becoming Telus Health.  

With how slow we are starting up Medi-Call I almost felt this was the direction they were going. Why spend tons of money scaling up when you can prove it works and sell it. If we had a company do that for Medi-call like Telus did, we would be getting close to a dollar a share. 

a bit of a dream on that, but the technology is worth money to the right company. For Now I want to see Toronto and Montreal added to the Vancouver list and for subscription and PR to start to grow after that. So by end of 2023 they feel in a strong enough position to start posting subscription numbers. 

<< Previous
Bullboard Posts
Next >>